Shares of Hydromer, Inc. (OTCMKTS:HYDI – Get Free Report) traded down 68.8% on Tuesday . The stock traded as low as $0.35 and last traded at $0.35. 500 shares were traded during mid-day trading, a decline of 57% from the average session volume of 1,162 shares. The stock had previously closed at $1.12.
Hydromer Stock Performance
The business has a 50 day moving average price of $0.60 and a two-hundred day moving average price of $0.42.
Hydromer Company Profile
Hydromer, Inc invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products.
Featured Stories
- Five stocks we like better than Hydromer
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Plot Fibonacci Price Inflection Levels
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 5 Top Rated Dividend Stocks to Consider
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Hydromer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydromer and related companies with MarketBeat.com's FREE daily email newsletter.